trial · primary record
SX-682
Head and Neck Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2037-10-01 |
| Primary endpoint | Phase I: To determine the RP2D of SX-682 in combination with DTX in participants with HNSCC, SGC, or mCRPC |
| Registry ID | NCT07667400 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:39.966Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07667400
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.